Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, Burazor I, Caforio ALP, Damy T, Eriksson U, et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial diseases. Eur Heart J. 2021;42(16):1554–68.

Article  PubMed  PubMed Central  Google Scholar 

Hahn VS, Yanek LR, Vaishnav J, Ying W, Vaidya D, Lee YZJ, Riley SJ, Subramanya V, Brown EE, Hopkins CD, et al. Endomyocardial Biopsy characterization of heart failure with preserved ejection fraction and prevalence of Cardiac Amyloidosis. JACC Heart Fail. 2020;8(9):712–24.

Article  PubMed  PubMed Central  Google Scholar 

Hotta VT, Giorgi MCP, Fernandes F, Abduch MCD, Falcão A, Mady C. Cardiac amyloidosis: non-invasive diagnosis. Rev Assoc Med Bras (1992) 2020, 66(3):345–352.

Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, Burazor I, Caforio ALP, Damy T, Eriksson U, et al. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial diseases. Eur J Heart Fail. 2021;23(4):512–26.

Article  PubMed  Google Scholar 

Ng PLF, Lim YC, Evangelista LKM, Wong RCC, Chai P, Sia CH, Loi HY, Yeo TC, Lin W. Utility and pitfalls of the electrocardiogram in the evaluation of cardiac amyloidosis. Ann Noninvasive Electrocardiol. 2022;27(4):e12967.

Article  PubMed  PubMed Central  Google Scholar 

Povar-Echeverría M, Auquilla-Clavijo PE, Povar-Marco BJ, Moreno-Esteban EM, Figueras-Villalba MP. Cardiac amyloidosis: a review of a series of cases. Arch Cardiol Mex. 2020;90(3):259–65.

PubMed  Google Scholar 

Mavrogeni SI, Vartela V, Ntalianis A, Vretou R, Ikonomidis I, Tselegkidou M, Paraskevaidis I, Markousis-Mavrogenis G, Noutsias M, Rigopoulos A, et al. Cardiac amyloidosis: in search of the ideal diagnostic tool. Herz. 2021;46(Suppl 1):9–14.

Article  PubMed  Google Scholar 

Rencuzogullari I, Çağdaş M, Karabağ Y, Karakoyun S, Çiftçi H, Gürsoy MO, Karayol S, Çinar T, Tanik O, Hamideyin Ş. A novel ECG parameter for diagnosis of acute pulmonary embolism: RS time: RS time in acute pulmonary embolism. Am J Emerg Med. 2019;37(7):1230–6.

Article  PubMed  Google Scholar 

Karakayali M, Artac I, Omar T, Rencuzogullari İ, Karabag Y, Cinar T, Altunova M, Hamideyin S. The association between frontal QRS-T angle and reverse dipper status in newly diagnosed hypertensive patients. Blood Press Monit. 2023;28(2):96–102.

Article  PubMed  Google Scholar 

Karakayali M, Artac I, Omar T, Rencuzogullari I, Karabag Y, Hamideyin S. Assessment of the efficacy of the electrocardiographic P-wave peak time in predicting atrial high rate episode in patients with cardiac implantable electronic devices. J Electrocardiol. 2023;80:40–4.

Article  PubMed  Google Scholar 

Sennott J, Ananthasubramaniam K. Multimodality imaging approach to cardiac amyloidosis: part 2. Heart Fail Rev. 2022;27(5):1515–30.

Article  PubMed  Google Scholar 

Rigopoulos AG, Ali M, Abate E, Torky AR, Matiakis M, Mammadov M, Melnyk H, Vogt A, de Vecchis R, Bigalke B, et al. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement. Heart Fail Rev. 2019;24(4):521–33.

Article  CAS  PubMed  Google Scholar 

Dominguez F. Predicting pacemaker implantation in cardiac amyloidosis: let’s start with an ECG. Eur J Heart Fail. 2022;24(7):1237–8.

Article  PubMed  Google Scholar 

Erbel-Khurtsidze S, Seibel R, Moka D, Brandt-Mainz K, Erbel R, Lichtenberg A. [Cardiac amyloidosis and aortic valve stenosis]. Herz. 2021;46(5):485–96.

Article  PubMed  Google Scholar 

Finocchiaro G, Sheikh N, Biagini E, Papadakis M, Maurizi N, Sinagra G, Pelliccia A, Rapezzi C, Sharma S, Olivotto I. The electrocardiogram in the diagnosis and management of patients with hypertrophic cardiomyopathy. Heart Rhythm. 2020;17(1):142–51.

Article  PubMed  Google Scholar 

Eicher JC, Audia S, Damy T. [Transthyretin cardiac amyloidosis]. Rev Med Interne. 2020;41(10):673–83.

Article  CAS  PubMed  Google Scholar 

Sharma S, Labib SB, Shah SP. Electrocardiogram Criteria to diagnose Cardiac Amyloidosis in Men with a Bundle Branch Block. Am J Cardiol. 2021;146:89–94.

Article  PubMed  Google Scholar 

Iijima T, Sawa N, Wake A, Kono K, Kinowaki K, Ubara Y, Ohashi K. Linear discriminant analysis on electrocardiogram achieved classification of cardiac involvement status in amyloid light-chain amyloidosis. J Cardiol. 2023;82(5):349–55.

Article  PubMed  Google Scholar 

Rahman JE, Helou EF, Gelzer-Bell R, Thompson RE, Kuo C, Rodriguez ER, Hare JM, Baughman KL, Kasper EK. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol. 2004;43(3):410–5.

Article  PubMed  Google Scholar 

Austin BA, Tang WH, Rodriguez ER, Tan C, Flamm SD, Taylor DO, Starling RC, Desai MY. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging. 2009;2(12):1369–77.

Article  PubMed  Google Scholar 

Cheng Z, Kang L, Tian Z, Chen W, Guo W, Xu J, Chen T, Fang L, Zeng Y, Cheng K, et al. Utility of combined indexes of electrocardiography and echocardiography in the diagnosis of biopsy proven primary cardiac amyloidosis. Ann Noninvasive Electrocardiol. 2011;16(1):25–9.

Article  PubMed  PubMed Central  Google Scholar 

Cheng Z, Zhu K, Tian Z, Zhao D, Cui Q, Fang Q. The findings of electrocardiography in patients with cardiac amyloidosis. Ann Noninvasive Electrocardiol. 2013;18(2):157–62.

Article  PubMed  Google Scholar 

Mussinelli R, Salinaro F, Alogna A, Boldrini M, Raimondi A, Musca F, Palladini G, Merlini G, Perlini S. Diagnostic and prognostic value of low QRS voltages in cardiac AL amyloidosis. Ann Noninvasive Electrocardiol. 2013;18(3):271–80.

Article  PubMed  PubMed Central  Google Scholar 

Di Bella G, Minutoli F, Piaggi P, Casale M, Mazzeo A, Zito C, Oreto G, Baldari S, Vita G, Pingitore A, et al. Usefulness of combining Electrocardiographic and echocardiographic findings and brain natriuretic peptide in early detection of Cardiac Amyloidosis in subjects with transthyretin gene mutation. Am J Cardiol. 2015;116(7):1122–7.

Article  PubMed  Google Scholar 

Huang J, Zhao S, Chen Z, Zhang S, Lu M. Contribution of Electrocardiogram in the differentiation of Cardiac Amyloidosis and Nonobstructive Hypertrophic Cardiomyopathy. Int Heart J. 2015;56(5):522–6.

Article  CAS  PubMed  Google Scholar 

Nicol M, Baudet M, Brun S, Harel S, Royer B, Vignon M, Lairez O, Lavergne D, Jaccard A, Attias D, et al. Diagnostic score of cardiac involvement in AL amyloidosis. Eur Heart J Cardiovasc Imaging. 2020;21(5):542–8.

Article  PubMed  Google Scholar 

Zhang KW, Zhang R, Deych E, Stockerl-Goldstein KE, Gorcsan J 3rd, Lenihan DJ. A multi-modal diagnostic model improves detection of cardiac amyloidosis among patients with diagnostic confirmation by cardiac biopsy. Am Heart J. 2021;232:137–45.

Article  CAS  PubMed  Google Scholar 

Grogan M, Lopez-Jimenez F, Cohen-Shelly M, Dispenzieri A, Attia ZI, Abou Ezzedine OF, Lin G, Kapa S, Borgeson DD, Friedman PA, et al. Artificial Intelligence-enhanced Electrocardiogram for the early detection of Cardiac Amyloidosis. Mayo Clin Proc. 2021;96(11):2768–78.

Article  PubMed  Google Scholar